Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DHAI DIH Holding US	$0.28 -5.2%	$0.25	$0.12 ▼ $2.93	$13.02M	0.07	3.34 million shs	3.03 million shs
LYRA Lyra Therapeutics	$7.02 -1.1%	$8.83	$3.81 ▼ $37.50	$11.54M	0.16	288,930 shs	5,207 shs
OSRH OSR	$0.50 -5.4%	$1.08	$0.48 ▼ $13.40	$10.82M	1.49	2.04 million shs	235,565 shs
UAHC United American Healthcare	$0.03 +52.9%	$0.02	$0.01 ▼ $0.11	$3.04M	-1.5	19,423 shs	1,550 shs

Beginner's Guide To Retirement Stocks

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DHAI DIH Holding US	-3.94%	+15.49%	+16.98%	+32.47%	-88.06%
LYRA Lyra Therapeutics	-3.01%	+5.04%	-10.25%	+50.85%	-54.55%
OSRH OSR	-5.30%	-5.64%	-49.97%	-53.87%	+53,029,900.00%
UAHC United American Healthcare	+4.94%	+8.28%	-29.17%	+20.57%	-76.06%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
DHAI DIH Holding US	0.3724 of 5 stars	0.0	3.0	0.0	0.0	1.1	1.7	0.0
LYRA Lyra Therapeutics	3.156 of 5 stars	3.0	5.0	0.0	0.0	2.6	2.5	0.6
OSRH OSR	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
UAHC United American Healthcare	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DHAI DIH Holding US	0.00	N/A	N/A	N/A
LYRA Lyra Therapeutics	2.00	Hold	$100.00	1,323.69% Upside
OSRH OSR	0.00	N/A	N/A	N/A
UAHC United American Healthcare	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest UAHC, LYRA, DHAI, and OSRH Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
8/14/2025	LYRA Lyra Therapeutics	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral

(Data available from 8/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DHAI DIH Holding US	$64.47M	0.20	N/A	N/A	($0.80) per share	-0.35
LYRA Lyra Therapeutics	$770K	15.01	N/A	N/A	$0.99 per share	7.09
OSRH OSR	N/A	N/A	N/A	N/A	$6.45 per share	N/A
UAHC United American Healthcare	N/A	N/A	N/A	N/A	N/A	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DHAI DIH Holding US	-$8.44M	-$0.30	N/A	∞	N/A	-13.59%	N/A	-25.97%	N/A
LYRA Lyra Therapeutics	-$93.43M	-$29.01	N/A	N/A	N/A	-5,043.64%	-404.56%	-60.06%	N/A
OSRH OSR	-$2.41M	N/A	0.00	∞	N/A	N/A	-12.19%	-8.18%	N/A
UAHC United American Healthcare	$240K	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A

Latest UAHC, LYRA, DHAI, and OSRH Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/14/2025	Q2 2025	OSRH OSR	N/A	$0.02	N/A	$0.02	N/A	$1.14 million
8/12/2025	Q2 2025	LYRA Lyra Therapeutics	-$5.79	-$5.51	+$0.28	-$5.51	$0.18 million	$0.29 million
5/20/2025	Q1 2025	OSRH OSR	N/A	-$1.04	N/A	-$1.04	N/A	$0.76 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
DHAI DIH Holding US	N/A	N/A	N/A	N/A	N/A
LYRA Lyra Therapeutics	N/A	N/A	N/A	N/A	N/A
OSRH OSR	N/A	N/A	N/A	N/A	N/A
UAHC United American Healthcare	$0.08	307.69%	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DHAI DIH Holding US	N/A	0.51	0.34
LYRA Lyra Therapeutics	N/A	2.78	2.78
OSRH OSR	N/A	0.18	0.20
UAHC United American Healthcare	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
DHAI DIH Holding US	27.76%
LYRA Lyra Therapeutics	95.62%
OSRH OSR	55.30%
UAHC United American Healthcare	N/A

Insider Ownership

Company	Insider Ownership
DHAI DIH Holding US	49.58%
LYRA Lyra Therapeutics	3.25%
OSRH OSR	33.67%
UAHC United American Healthcare	14.31%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
DHAI DIH Holding US	N/A	47.34 million	23.87 million	N/A
LYRA Lyra Therapeutics	50	1.65 million	1.59 million	Optionable
OSRH OSR	N/A	21.58 million	12.79 million	N/A
UAHC United American Healthcare	31	117.06 million	100.31 million	Not Optionable

UAHC, LYRA, DHAI, and OSRH Headlines

Recent News About These Companies

Molina Healthcare (NYSE:MOH) & United American Healthcare (OTCMKTS:UAHC) Head-To-Head Contrast

August 13, 2025 | americanbankingnews.com

United American Healthcare (OTCMKTS:UAHC) versus UnitedHealth Group (NYSE:UNH) Head to Head Contrast

August 13, 2025 | americanbankingnews.com

United American Healthcare (OTCMKTS:UAHC) versus Centene (NYSE:CNC) Critical Review

August 11, 2025 | americanbankingnews.com

United American Healthcare CorpShs

May 6, 2025 | markets.businessinsider.com

United Healthcare data breach may have affected 190 million Americans

January 27, 2025 | msn.com

UnitedHealth CEO: American healthcare needs to be "less complex and less confusing'

January 17, 2025 | msn.com

UnitedHealth tops profit forecasts but medical costs linger for health care giant

January 16, 2025 | msn.com

News Wrap: United Healthcare CEO killed in brazen and targeted attack, New York police say

December 5, 2024 | pbs.orgP

HH Health System, United Healthcare reach agreement

November 14, 2024 | elkvalleytimes.comE

United Healthcare reaches deal with Huntsville Hospital Health System

November 14, 2024 | decaturdaily.comD

How will a Trump presidency reshape US public health? A look at his plans.

November 13, 2024 | usatoday.com

Dreamers eligible for health insurance through Covered California for first time this year

November 8, 2024 | thecalifornian.comT

Duke Health, UnitedHealthcare reach multi-year agreement, impacts over 172K patients

November 3, 2024 | msn.com

As ACA sign ups start, more Americans have health insurance than ever. Will it last?

November 2, 2024 | msn.com

USA Health sets gala to celebrate health care workers’ impact on patients

October 31, 2024 | msn.com

UnitedHealth Confirms Change Healthcare Data Breach Impacted 100 Million Americans

October 29, 2024 | cpomagazine.comC

More than 100 million Americans had their health data exposed in a UnitedHealth hack

October 26, 2024 | 9to5mac.com9

Cyberattack at UnitedHealth subsidiary Change Healthcare affected 100M Americans

October 24, 2024 | startribune.comS

More than 1,500 physicians call on Trump to release health care plan

October 18, 2024 | msn.com

New center aims to enhance public health preparedness in Utah and beyond

October 11, 2024 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

UAHC, LYRA, DHAI, and OSRH Company Descriptions

DIH Holding US NASDAQ:DHAI

$0.28 -0.02 (-5.21%)

Closing price 03:58 PM Eastern

Extended Trading

$0.27 -0.01 (-2.18%)

As of 04:14 PM Eastern

DIH Holding US, Inc. operates as a robotics and virtual reality (VR) technology provider for the rehabilitation industry in Europe, the Middle East, Africa, the United States, and the Asia Pacific. It offers ArmeoPower, a backbone robot for arm and hand therapy in an early stage of rehabilitation; ArmeoSpring for less severe patients that provides self-initiated repetitive arm and hand therapy in an extensive workspace; ArmeoSpring Pro; and Armeo Senso, for patients self-initiated and still structurally controlled movement patterns to completely open movement. The company also provides lower extremity products, including Erigo for gradual verticalization, leg mobilization, and intensive sensorimotor stimulation through cyclic leg loading; Lokomat, a robot-assisted therapy that enables training to increase the strength of muscles and a range of motion of joints in order to improve walking; Andago, a robotics smart control system that assists patients in walking naturally; C-Mill, creates a training environment; CAREN, a computer assisted rehabilitation environment; and GRAIL, an gait real-time analysis interactive lab solution for analysis training and research. In addition, it offers SafeGait, RYSEN, and M-Gait for gait and balance; and HocoNet and D-Flow software. DIH Holding US, Inc. was founded in 2021 and is based in Norwell, Massachusetts.

Lyra Therapeutics NASDAQ:LYRA

$7.04 -0.05 (-0.72%)

As of 04:00 PM Eastern

Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable drug matrix for the treatment of chronic rhinosinusitis (CRS), which is in Phase III clinical trial; and LYR-220 for CRS patients with and without nasal polyps. It has a collaboration agreement with LianBio Inflammatory Limited to develop and commercialize LYR-210 in mainland China, Hong Kong, Taiwan, Macau, South Korea, Singapore, and Thailand. The company was formerly known as 480 Biomedical, Inc. and changed its name to Lyra Therapeutics, Inc. in July 2018. Lyra Therapeutics, Inc. was incorporated in 2005 and is headquartered in Watertown, Massachusetts.

OSR NASDAQ:OSRH

$0.50 -0.03 (-5.45%)

As of 03:53 PM Eastern

OSR Holdings leverages its international network of partners in the US, Europe, and South Korea to market and license its pipeline of proprietary platform technologies for broad application to efficient clinical trial programs, with the ultimate goal of addressing unmet medical needs. We partner with biotherapeutics companies with innovative and proprietary drug R&D "platform technologies" versus "assets only" companies, whose commercial viability is heavily dependent on positive results for individual treatment modalities in extremely rigorous and time consuming clinical trials. We focus on value creation through investments and collaborations with US and EU biotech companies, with the strategic goal of expansion into South Korea (specifically) and Asia (generally). OSR Holdings is headquartered in Paju, South Korea.

United American Healthcare OTCMKTS:UAHC

$0.03 +0.01 (+52.94%)

As of 02:44 PM Eastern

United American Healthcare Corporation, through its subsidiaries, provides contract manufacturing services to the medical device industry. It also focuses on the production of natural rubber. The company was incorporated in 1983 and is based in Chicago, Illinois.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time